ストックスクリーナーアプリを入手
13.28
2.58%
0.3344
アフターアワーズ：
13.27
-0.010
-0.08%
前日終値:
$12.95
開ける：
$13.29
24時間の取引高:
5,087
Relative Volume:
0.18
時価総額：
$64.23M
収益：
$2.61M
当期純損益:
$1.69M
株価収益率:
44.22
EPS:
0.3003
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.11%
1か月 パフォーマンス:
+11.78%
6か月 パフォーマンス:
+79.20%
1年 パフォーマンス:
+45.45%
1日の値動き範囲:
$12.89
$13.33
1週間の範囲:
$12.52
$13.33
52週間の値動き範囲:
$6.55
$14.00
Daxor Corporation Stock (DXR) Company Profile
名前
Daxor Corporation
セクター
電話
212-330-8500
住所
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
DXR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
13.28 | 64.53M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
458.47 | 159.93B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
191.00 | 54.20B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
271.41 | 39.13B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.46 | 37.13B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
274.90 | 19.46B | 2.96B | 487.70M | 344.00M | 6.6758 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-05-16 | 開始されました | Ascendiant Capital Markets | Buy |
Daxor Corporation (DXR) 最新ニュース
How Daxor Corporation (DX5) stock behaves under inflation pressure2025 Historical Comparison & Fast Entry High Yield Tips - nchmf.gov.vn
Will Daxor Corporation (DX5) stock extend growth storyMarket Performance Recap & Technical Confirmation Trade Alerts - newser.com
How strong is Daxor Corporation (DX5) stock earnings growthMarket Performance Summary & AI Powered Market Trend Analysis - newser.com
Is Daxor Corporation (DX5) stock attractive for dividend growthMarket Risk Analysis & Fast Entry High Yield Tips - nchmf.gov.vn
Is Daxor Corporation stock a buy before product launchesPortfolio Value Summary & Weekly Consistent Profit Watchlists - newser.com
Can technical indicators confirm Daxor Corporation’s reversalMarket Activity Report & Fast Moving Stock Watchlists - newser.com
Can Daxor Corporation (DX5) stock retain market dominance2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Why Daxor Corporation (DX5) stock could rally stronglyTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Why analysts raise outlook for Daxor Corporation (DX5) stockPortfolio Return Report & Accurate Buy Signal Notifications - newser.com
Chart overlay techniques for tracking Daxor Corporation2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
Sector ETF performance correlation with Daxor CorporationWeekly Profit Report & Fast Gaining Stock Reports - newser.com
Will Daxor Corporation (DX5) stock outperform benchmarks2025 Performance Recap & Weekly High Momentum Picks - newser.com
What earnings revisions data tells us about Daxor Corporation2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
Will Daxor Corporation stock maintain dividend yieldJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
Head-To-Head Comparison: Bioqual (OTCMKTS:BIOQ) and Daxor (NASDAQ:DXR) - Defense World
Is Daxor Corporation reversing from oversold territory2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
Is Daxor Corporation stock poised for growthExit Point & Weekly Watchlist for Hot Stocks - newser.com
Can Daxor Corporation stock beat analyst upgradesPortfolio Value Summary & Weekly Return Optimization Plans - nchmf.gov.vn
Quarterly Risk: Is Daxor Corporation (DX5) stock undervalued by metricsWeekly Trend Recap & Safe Entry Trade Reports - nchmf.gov.vn
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference - MSN
Using data filters to optimize entry into Daxor CorporationIPO Watch & High Return Stock Watch Alerts - newser.com
Full technical analysis of Daxor Corporation stockDividend Hike & Weekly High Return Stock Forecasts - newser.com
Daxor (DXR) to Showcase at Cardiovascular Conference in Austin - GuruFocus
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25 - GlobeNewswire
Next‑Gen BVA System: Daxor Debuts Blood‑Volume Diagnostic at MedAxiom CV Transforum Oct 16–18 - Stock Titan
[N-CSR/A] – DAXOR CORP (DXR) (CIK 0000027367) | DXR SEC FilingForm N-CSR/A - Stock Titan
Using fundamentals and technicals on Daxor CorporationJuly 2025 WrapUp & Weekly Sector Rotation Insights - newser.com
Can Daxor Corporation stock sustain free cash flow growthJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
Daxor Corporation (DXR) 財務データ
収益
当期純利益
現金流量
EPS
2.71%
大文字化:
|
ボリューム (24 時間):